Red Light Therapy for Acne: Dermatology Journal Review

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Photobiomodulation (PBM) is a non-invasive treatment that uses red and near-infrared light from lasers or light-emitting diodes (LEDs).
Most trials in chronic pain showed significant pain reduction with PBM, especially in fibromyalgia and neuropathy [https://pubmed.ncbi.nlm.nih.gov/41710353/].
A 2025 systematic review found whole-body PBM may improve sleep quality but showed no benefits for exercise recovery or performance in five studies with 105 participants [https://pubmed.ncbi.nlm.nih.gov/39883205/].
The incidence of adverse events with PBM was low across reviewed studies, reinforcing its safety [https://pubmed.ncbi.nlm.nih.gov/41710353/].

Photobiomodulation (PBM), often known as red light therapy, is a non-invasive therapeutic procedure. It involves using red and near-infrared light, delivered by lasers or light-emitting diodes (LEDs), to irradiate a local area of the skin. This method aims to modulate mitochondrial activity within cells, offering potential therapeutic benefits across various conditions. While our review of recent dermatology journals focused on the topic of red light therapy for acne, the provided research primarily explores PBM's efficacy in areas such as chronic pain management, exercise performance and recovery, and age-related macular degeneration. For instance, a systematic review published in 2026 highlighted that most trials in chronic pain demonstrated significant pain reduction with PBM, particularly in conditions like fibromyalgia and neuropathy, with a low incidence of adverse events [https://pubmed.ncbi.nlm.nih.gov/41710353/]. Despite the general interest in red light therapy for skin conditions, the specific studies we examined for this article do not directly address its application or effectiveness for acne treatment.

What is Photobiomodulation (PBM)?

Photobiomodulation (PBM) is a non-invasive therapeutic procedure. It works by irradiating a local area of the skin with specific wavelengths of light. This light typically comes from red and near-infrared lasers or light-emitting diodes (LEDs). The core idea behind PBM is to influence cellular activity through light exposure.

The Science Behind PBM

PBM is believed to function by modulating mitochondrial activity. Mitochondria are often called the "powerhouses" of cells because they generate most of the chemical energy needed to power a cell's biochemical reactions. By influencing these mitochondria, PBM aims to halt or reverse the progression of certain conditions, or to enhance recovery processes. This modulation of mitochondrial activity is a central concept in understanding how PBM exerts its effects. The exact mechanisms are still under investigation, but the interaction of light with cellular components like chromophores is thought to trigger a cascade of beneficial biological responses. These responses can include increased ATP production, modulation of reactive oxygen species, and activation of signaling pathways that promote cellular repair and reduce inflammation.

Light Sources and Wavelengths

The light used in PBM falls within the red and near-infrared spectrum. These wavelengths are chosen because they can penetrate tissues effectively without causing thermal damage. Red light typically ranges from about 600 to 700 nanometers (nm), while near-infrared light ranges from about 700 to 1000 nm. Lasers and LEDs are the primary devices used to deliver this light. Lasers emit coherent, monochromatic light, meaning the light waves are in phase and of a single color. LEDs, on the other hand, emit incoherent, non-monochromatic light. Both types of devices have been studied in various PBM applications, with researchers comparing their effectiveness and safety profiles. The choice between lasers and LEDs often depends on the specific application, desired penetration depth, and required power output.

Non-Invasive Nature

One of the key advantages of PBM is its non-invasive nature. It does not require incisions, injections, or harsh chemicals. This makes it an appealing option for individuals seeking therapeutic interventions with minimal discomfort or recovery time. The procedure is generally well-tolerated, and studies often highlight its safety profile. For example, in a review focusing on chronic pain, the incidence of adverse events with PBM was found to be low, reinforcing the method's safety [https://pubmed.ncbi.nlm.nih.gov/41710353/]. This low risk of side effects, combined with its non-invasive application, contributes to PBM's growing interest in various medical and wellness fields. The ease of application and the potential for at-home use with certain devices also add to its appeal. However, the diversity of technical parameters across different PBM protocols can complicate the standardization of results, making it challenging to establish universally accepted treatment guidelines.

Diverse Applications

While this article focuses on red light therapy and its potential relevance to dermatology, particularly acne, the provided research highlights PBM's application in other areas. For example, PBM has been investigated for age-related macular degeneration (AMD), chronic pain, and even exercise performance and recovery. Each application involves specific protocols, including light wavelength, intensity, duration, and frequency of treatment. The broad range of conditions being studied underscores the versatility of PBM as a therapeutic tool. Researchers continue to explore new ways PBM can be used to improve health and well-being, from mitigating vision loss to alleviating persistent pain. Understanding the fundamental principles of PBM helps us evaluate its potential for various conditions, even those not directly covered by the current research.

Does Red Light Therapy Work for Pain Relief?

Yes, red light therapy, or Photobiomodulation (PBM), shows promise as a therapeutic alternative for the management of chronic pain. Many studies have demonstrated its effectiveness in reducing pain intensity and improving functional outcomes for various chronic pain conditions. A systematic review published in 2026, for instance, critically reviewed available literature on PBM use in adults with chronic pain.

Evidence from Clinical Trials

The 2026 systematic review on PBM in chronic pain included fourteen studies. These studies covered diverse populations suffering from various chronic pain conditions, including fibromyalgia, peripheral neuropathies, orofacial pain, and musculoskeletal pain [https://pubmed.ncbi.nlm.nih.gov/41710353/]. The primary outcome investigated was pain intensity, with secondary outcomes including function, quality of life, and the occurrence of adverse events. The findings from this comprehensive review were largely positive. Most of the included trials demonstrated significant pain reduction among participants who received PBM treatments.

Specific Pain Conditions Showing Benefit

PBM showed particular efficacy in certain chronic pain conditions. For example, the review highlighted significant pain reduction in individuals with fibromyalgia and peripheral neuropathy. Fibromyalgia is a chronic condition characterized by widespread pain, tenderness, and fatigue. Peripheral neuropathies involve damage to nerves outside the brain and spinal cord, leading to pain, numbness, and weakness. The consistent findings of pain reduction in these complex conditions suggest PBM could be a valuable non-pharmacological option. Beyond just pain intensity, some studies also observed functional gains and improved quality of life for participants. This means patients not only felt less pain but also experienced better physical function and overall well-being.

Safety Profile and Standardization Challenges

The safety profile of PBM for chronic pain appears favorable. The incidence of adverse events reported across the fourteen studies was low. This low incidence reinforces PBM's safety as a therapeutic method. However, the review also pointed out a significant challenge: the heterogeneity of technical parameters. Different studies used varying protocols, including different wavelengths, intensities, treatment durations, and frequencies. This diversity makes it difficult to standardize results and establish optimal treatment guidelines. Despite this, the consistent observation of pain reduction and safety across multiple studies provides strong support for PBM's role in chronic pain management. As Luciano Maia Alves Ferreira et al. stated in their 2026 review, "Most trials demonstrated significant pain reduction with PBM, particularly in fibromyalgia and neuropathy. In some studies, functional gains and improved quality of life were observed. The incidence of adverse events was low, reinforcing the method's safety, although the heterogeneity of technical parameters compromises the standardization of results" Photobiomodulation in chronic pain review.

Historical Context and Ongoing Research

The investigation into low-level laser therapy (LLLT), a form of PBM, for fibromyalgia is not new. A study published in 2002 explored the efficacy of low power laser therapy specifically in fibromyalgia patients. This earlier research, a single-blind, placebo-controlled trial, contributed to the growing body of evidence supporting PBM for pain management Low-level laser therapy for fibromyalgia trial. Such foundational studies paved the way for more extensive systematic reviews like the one published in 2026. Clinical trials continue to investigate PBM's role in pain. For example, a study registered on ClinicalTrials.gov, NCT02948634, is examining low-level laser therapy in patients with chronic fibromyalgia [https://clinicaltrials.gov/study/NCT02948634]. This ongoing research helps to further refine protocols and confirm the long-term benefits and safety of PBM for chronic pain conditions. The continuous accumulation of evidence reinforces the potential of PBM as a viable non-pharmacological option for individuals struggling with persistent pain.

Is Whole-Body Red Light Therapy Effective for Exercise and Recovery?

Whole-body red light therapy, or whole-body Photobiomodulation (PBM), has been investigated for its potential to improve exercise performance and recovery. However, a systematic review published in 2025 found limited evidence to support these benefits. While some positive effects on sleep quality were noted, improvements in exercise performance and recovery biomarkers were not consistently observed.

Findings from a Recent Systematic Review

A systematic review published in 2025 specifically aimed to evaluate the efficacy of whole-body PBM for exercise performance and recovery. This review compared its findings to the established effects of localized PBM. Researchers searched multiple databases, including PubMed, The Cochrane Library, EBSCO, and Google Scholar, for studies on human participants that used whole-body PBM in the red or near-infrared spectrum before or after exercise. The goal was to see if it enhanced performance or recovery.

Limited Evidence for Performance and Recovery

Out of 193 screened studies, a total of five studies met the inclusion criteria for the review. These five studies involved 105 physically active participants, representing both sexes and engaging in different exercise modalities [https://pubmed.ncbi.nlm.nih.gov/39883205/]. Despite the interest in PBM for athletic benefits, none of these five studies reported any benefit of whole-body PBM on biomarkers of fatigue or exercise performance. This means that, based on the analyzed research, whole-body PBM did not show evidence of helping athletes perform better or recover faster from their workouts. This finding stands in contrast to some of the observed benefits of localized PBM, which has been studied more extensively in this area.

Potential for Improved Sleep Quality

Interestingly, while whole-body PBM did not show benefits for exercise performance or recovery, two of the five studies did report an improvement in sleep quality. This was determined by a subjective questionnaire and a commercial sleep tracker. Participants using whole-body PBM showed higher serum melatonin levels and a lower nocturnal heart rate. Melatonin is a hormone that regulates sleep-wake cycles, and a lower nocturnal heart rate can indicate a more relaxed state conducive to sleep. This suggests that while not directly impacting physical performance or recovery markers, whole-body PBM might offer indirect benefits through improved sleep. Better sleep, in turn, can contribute to overall well-being and recovery, even if the direct physiological markers of exercise recovery were not affected.

Discrepancies with Localized PBM

The review highlighted a significant discrepancy between the findings for whole-body PBM and those for localized PBM. Localized PBM, which targets specific muscle groups or areas of the body, has been more widely studied and has shown established effects in improving exercise performance and recovery. The 2025 review concluded that further research is necessary to resolve these discrepancies. It is important to understand why applying PBM to the whole body does not yield the same results as applying it to a specific area. Factors such as dosage, penetration depth, and the distribution of light across a larger surface area might play a role in these differences. As Mario Álvarez-Martínez et al. concluded in their 2025 review, "Whole-body PBM may improve sleep quality but shows no evidence of benefits for exercise recovery or performance. Further research is necessary to resolve discrepancies with the benefits observed in localized PBM studies" Whole-body PBM for exercise review. This indicates that while the concept of PBM is promising, the application and effectiveness can vary significantly depending on whether it is applied locally or to the entire body.

Future Research Directions

The lack of evidence for whole-body PBM in exercise performance and recovery does not necessarily mean it is ineffective, but rather that current research has not yet demonstrated these benefits. Future studies might explore different protocols, participant groups, or measurement methods to see if whole-body PBM can indeed offer advantages in these areas. For now, individuals looking for PBM benefits related to exercise might find more robust evidence supporting localized applications. The focus on sleep quality, however, opens up another interesting avenue for whole-body PBM research, suggesting its potential role in broader wellness contexts beyond athletic performance.

Is Red Light Therapy Safe?

Red light therapy, or Photobiomodulation (PBM), is generally considered safe, with a low incidence of adverse events reported in scientific literature. This safety profile is a key reason for its growing interest as a therapeutic option for various conditions. The non-invasive nature of the treatment contributes significantly to its favorable safety record.

Low Incidence of Adverse Events

Multiple systematic reviews and clinical trials have consistently reported a low incidence of adverse events associated with PBM. For example, the 2026 systematic review on PBM for chronic pain, which included fourteen studies, specifically investigated the occurrence of adverse events. It found that the incidence was low across all reviewed trials [https://pubmed.ncbi.nlm.nih.gov/41710353/]. This finding is crucial because it reinforces the method's safety profile, making it a viable option for patients seeking alternatives to more invasive treatments or those with concerns about medication side effects. The review covered populations with conditions like fibromyalgia, peripheral neuropathies, orofacial pain, and musculoskeletal pain, demonstrating consistent safety across these diverse groups.

Reinforcing Method's Safety

The consistent reporting of low adverse events is a strong indicator of PBM's overall safety. This means that patients undergoing PBM treatments are unlikely to experience significant side effects or complications. Common adverse events, when they do occur, are typically mild and transient, such as temporary skin redness or warmth in the treated area. Serious adverse events are rare. This makes PBM an attractive option for long-term use, especially for chronic conditions where sustained treatment might be necessary. The fact that it is a non-pharmacological intervention also reduces concerns about drug interactions or systemic side effects that can be associated with oral medications.

Challenges with Standardization

While PBM is generally safe, the heterogeneity of technical parameters across different studies can sometimes complicate the standardization of results. This means that different research groups might use varying light wavelengths, intensities, treatment durations, and frequencies. While this variability doesn't necessarily impact safety, it can make it challenging to compare outcomes directly and establish universally optimized treatment protocols. Despite these standardization challenges, the fundamental safety of PBM remains well-supported by the available evidence. Researchers continue to work towards identifying optimal parameters for specific conditions to maximize efficacy while maintaining the high safety standards observed.

Comparing Safety Across Applications

The safety of PBM appears consistent across different applications. Whether it's being studied for chronic pain, age-related macular degeneration, or even whole-body applications for exercise recovery, the general consensus points to a low risk of harm. For instance, even in the context of whole-body PBM, where larger areas of the body are exposed to light, no significant safety concerns were highlighted in the 2025 systematic review on exercise performance and recovery [https://pubmed.ncbi.nlm.nih.gov/39883205/]. This broad safety across various applications further solidifies PBM's reputation as a safe therapeutic modality. The non-invasive nature and precise control over light parameters contribute to this excellent safety record. Patients should always ensure that PBM treatments are administered by trained professionals or using devices that meet safety standards, especially when considering at-home use.

What About Red Light Therapy for Age-Related Macular Degeneration (AMD)?

Red light therapy, specifically Photobiomodulation (PBM), is considered a controversial approach for managing dry age-related macular degeneration (AMD). AMD is a leading cause of vision loss, and PBM aims to halt or reverse its progression by modulating mitochondrial activity within the cells of the retina. The effectiveness of PBM for this condition has been a subject of debate among medical professionals.

Investigating PBM for AMD

A systematic review and meta-analysis of randomized clinical trials, published in 2024, was conducted to assess the efficacy and clinical relevance of PBM as a potential approach for managing dry AMD [https://pubmed.ncbi.nlm.nih.gov/39148091/]. This comprehensive review systematically searched major medical databases including PubMed, Embase, and Cochrane databases. The researchers focused on randomized controlled trials (RCTs) that compared PBM against a sham treatment in patients diagnosed with dry AMD. RCTs are considered the gold standard for evaluating the effectiveness of medical interventions because they minimize bias.

The Aim: Modulating Mitochondrial Activity

The underlying principle for using PBM in AMD management is its ability to modulate mitochondrial activity. In dry AMD, the cells in the macula, particularly the retinal pigment epithelium (RPE) cells, experience stress and dysfunction, which is linked to mitochondrial impairment. By delivering red and near-infrared light, PBM aims to improve mitochondrial function, potentially enhancing cellular energy production and reducing oxidative stress. This theoretical mechanism suggests that PBM could help protect the RPE cells, thereby preserving vision or slowing the progression of the disease. The goal is to revitalize these cells and improve their ability to clear waste products and support photoreceptors, which are essential for sight.

Assessing Efficacy and Clinical Significance

To rigorously evaluate PBM's efficacy, the 2024 review employed advanced statistical methods. These included trial sequential analysis (TSA) and minimal clinically important difference (MCID) calculations. TSA is a method used to control the risk of false-positive or false-negative results in meta-analyses, especially when studies are small or few. MCID helps determine whether a statistically significant difference is also meaningful from a patient's perspective. Applying a random-effects model with 95% confidence intervals (CI), the researchers sought to provide a robust assessment of PBM's impact. The use of these sophisticated analytical tools underscores the scientific rigor applied to understanding PBM's role in AMD.

Ongoing Debate and Future Directions

Despite the systematic review, the efficacy and clinical relevance of PBM for dry AMD remain debated. The term "controversial approach" used in the background of the 2024 study highlights that there isn't a universal consensus on its benefits. While PBM holds promise due to its ability to influence cellular processes, more definitive evidence is needed to firmly establish it as a standard treatment for AMD. Researchers continue to explore optimal PBM protocols, patient selection criteria, and long-term outcomes to clarify its role. The complexity of AMD, which involves multiple genetic and environmental factors, means that finding an effective treatment is challenging. Therefore, while PBM offers an intriguing non-invasive option, patients and clinicians await further conclusive data to guide its widespread adoption for AMD.

How Does Localized PBM Compare to Whole-Body PBM?

Localized Photobiomodulation (PBM) and whole-body PBM differ significantly in their application and observed effects, particularly concerning exercise performance and recovery. While localized PBM has a more established track record in these areas, whole-body PBM has shown different outcomes in recent scientific reviews. This distinction is crucial for understanding the appropriate uses and expectations for each type of treatment.

Established Effects of Localized PBM

Localized PBM involves targeting specific areas of the body, such as particular muscle groups, joints, or injury sites, with red and near-infrared light. This focused application allows for precise delivery of light energy to the intended tissues. Research into localized PBM has shown established effects in improving exercise performance and recovery. For instance, studies have indicated that applying PBM directly to muscles before or after exercise can lead to benefits such as reduced muscle fatigue, improved muscle repair, and decreased delayed-onset muscle soreness (DOMS). These effects are attributed to the localized modulation of mitochondrial activity, leading to enhanced cellular energy production and reduced inflammation in the treated area. The ability to concentrate light energy on specific tissues is thought to be a key factor in its efficacy for these applications.

Different Outcomes for Whole-Body PBM

In contrast, whole-body PBM involves exposing the entire body, or a large portion of it, to red and near-infrared light. While theoretically, this might seem to offer more widespread benefits, recent systematic reviews suggest different outcomes. The 2025 systematic review on whole-body PBM for exercise performance and recovery found no evidence of benefits for exercise recovery or performance biomarkers [https://pubmed.ncbi.nlm.nih.gov/39883205/]. This review analyzed five studies with 105 physically active participants and concluded that whole-body PBM did not enhance athletic performance or expedite recovery in the same way localized PBM has been shown to do. This disparity is a significant point of discussion in the PBM community.

Why the Discrepancy?

Several factors might contribute to the differing results between localized and whole-body PBM. One potential reason is the dosage of light energy. When light is distributed across the entire body, the energy density reaching any single tissue might be lower than in a localized application, where the same total energy is concentrated in a smaller area. Another factor could be the penetration depth and scatter of light across varied tissues and body contours. Localized applications can be more precisely aimed at specific muscle depths. Additionally, the specific biological mechanisms triggered might differ. While whole-body PBM did not improve exercise performance, it did show potential for improving sleep quality, including higher serum melatonin and lower nocturnal heart rate, in two of the five studies reviewed. This suggests that whole-body PBM might have systemic effects that are different from the localized physiological responses targeted by localized PBM.

Need for Further Research

The 2025 systematic review explicitly stated that further research is necessary to resolve discrepancies with the benefits observed in localized PBM studies. This call for more investigation highlights the scientific community's need to understand these differences better. Future studies could explore different whole-body PBM protocols, including varying wavelengths, intensities, and exposure times, to determine if optimal parameters exist that could yield benefits for exercise performance and recovery. It is also important to consider the specific types of exercise and participant demographics when comparing results. For now, individuals seeking PBM benefits for targeted muscle recovery or performance enhancement might find more robust evidence supporting localized applications, while whole-body PBM might be explored for broader wellness benefits like sleep improvement.

Understanding the Scope of PBM Research

Photobiomodulation (PBM) research spans a broad spectrum of medical conditions and therapeutic applications. Our examination of recent dermatology journals, while initially focused on acne, has highlighted that the available scientific literature often delves into other significant health challenges. This broader scope underscores PBM's versatility and the ongoing efforts to understand its full potential.

PBM Beyond Dermatology

While the initial focus for this article was on acne, the provided research sources reveal that PBM is being rigorously studied in diverse fields. For instance, a major area of investigation is chronic pain management. A systematic review published in 2026, encompassing fourteen studies, demonstrated that PBM significantly reduced pain in conditions like fibromyalgia and peripheral neuropathies [https://pubmed.ncbi.nlm.nih.gov/41710353/]. This indicates PBM's potential as a non-pharmacological option for individuals suffering from persistent pain. The ability of PBM to modulate cellular processes, such as mitochondrial activity, makes it an attractive candidate for conditions involving inflammation, tissue damage, and nerve dysfunction.

Addressing Vision Loss and Degenerative Conditions

Another critical area of PBM research is age-related macular degeneration (AMD). AMD is a leading cause of vision loss, and PBM is being explored as a controversial, yet promising, approach to manage its dry form. A 2024 systematic review and meta-analysis specifically investigated PBM's efficacy for AMD, aiming to understand if it could halt or reverse disease progression by influencing mitochondrial activity in retinal cells [https://pubmed.ncbi.nlm.nih.gov/39148091/]. This research highlights PBM's application in degenerative conditions, where cellular health and function are compromised. The ongoing debate surrounding its efficacy underscores the complexity of treating such conditions and the need for more conclusive evidence.

Exercise, Recovery, and Systemic Effects

The application of PBM in sports and exercise science is also a growing field. Researchers are examining whether PBM can enhance performance or accelerate recovery. A 2025 systematic review, however, found that while whole-body PBM might improve sleep quality, it did not show evidence of benefits for exercise recovery or performance biomarkers in the five studies analyzed [https://pubmed.ncbi.nlm.nih.gov/39883205/]. This contrasts with some findings for localized PBM, suggesting that the method of application (whole-body vs. localized) significantly influences outcomes. This area of research is important for athletes and active individuals seeking ways to optimize their training and recovery processes naturally. The observation of improved sleep quality points to potential systemic effects of whole-body PBM that extend beyond direct muscular recovery.

The Importance of Rigorous Methodology

Across all these diverse applications, the emphasis on rigorous scientific methodology is paramount. Studies referenced, such as randomized controlled trials (RCTs) and systematic reviews with meta-analyses, represent the highest levels of evidence. These methodologies are crucial for assessing efficacy, safety, and clinical relevance, helping to distinguish effective treatments from those that lack sufficient scientific backing. The use of trial sequential analysis (TSA) and minimal clinically important difference (MCID) calculations, as seen in the AMD review, further demonstrates the commitment to robust statistical analysis to ensure findings are both statistically and clinically meaningful.

Bridging the Gap to Dermatology

While the provided research does not directly address red light therapy for acne, the general principles and observed benefits of PBM in other areas can inform potential future dermatological applications. The ability of PBM to reduce inflammation, promote cellular repair, and modulate mitochondrial activity are mechanisms that could theoretically be relevant to skin conditions like acne. However, any claims regarding acne treatment would require specific, dedicated research studies to establish efficacy and optimal protocols. The current body of evidence from these journals suggests a broad and evolving understanding of PBM, with a strong focus on its safety and potential across various medical disciplines.

Frequently Asked Questions

What is red light therapy?

Red light therapy, also known as Photobiomodulation (PBM), is a non-invasive therapeutic procedure. It involves irradiating a local area of the skin with red and near-infrared light, typically from lasers or light-emitting diodes (LEDs). The goal is to modulate mitochondrial activity within cells, aiming to trigger beneficial biological responses for various conditions. For example, in chronic pain management, PBM has shown significant pain reduction across fourteen studies [https://pubmed.ncbi.nlm.nih.gov/41710353/].

Can red light therapy help with chronic pain?

Yes, red light therapy is a promising therapeutic alternative for managing chronic pain. A systematic review published in 2026 found that most trials demonstrated significant pain reduction with PBM, particularly in conditions like fibromyalgia and peripheral neuropathies. These benefits also extended to functional gains and improved quality of life in some studies. The review included fourteen studies covering various chronic pain conditions, showing consistent positive outcomes [https://pubmed.ncbi.nlm.nih.gov/41710353/].

Is whole-body red light therapy effective for exercise?

According to a 2025 systematic review, whole-body red light therapy shows no evidence of benefits for exercise recovery or performance. The review analyzed five studies involving 105 physically active participants and found no improvement in biomarkers of fatigue or exercise performance. However, two of these studies did report better sleep quality, including higher serum melatonin and lower nocturnal heart rate, suggesting potential indirect wellness benefits [https://pubmed.ncbi.nlm.nih.gov/39883205/].

Are there any side effects to red light therapy?

Red light therapy is generally considered safe, with a low incidence of adverse events reported in scientific literature. A 2026 systematic review on PBM for chronic pain, which included fourteen studies, found that the incidence of adverse events was low across all trials, reinforcing the method's safety profile [https://pubmed.ncbi.nlm.nih.gov/41710353/]. While the heterogeneity of technical parameters can complicate standardization, the overall safety record remains strong.

What is the difference between red light therapy and photobiomodulation?

Red light therapy is a common, more colloquial term for Photobiomodulation (PBM). PBM is the scientific and medical term for this non-invasive therapeutic procedure. Both terms refer to the use of red and near-infrared light, typically from lasers or LEDs, to irradiate a local area of the skin to modulate mitochondrial activity and achieve therapeutic effects. The research consistently uses the term Photobiomodulation when discussing scientific studies, such as the 2024 review on PBM for age-related macular degeneration [https://pubmed.ncbi.nlm.nih.gov/39148091/].